Philip Krause
Vermogen: 486 246 $ op 31-08-2026
Vermogen: 486 246 $ op 31-08-2026
Dr. Philip R.
Krause is on the Board of Directors at Mesoblast Ltd. Dr. Krause was previously employed as a Deputy Director by US Food & Drug Administration.
He received his undergraduate degree from the University of Illinois, a graduate degree from the University of Illinois, an MBA from Florida State University and a doctorate degree from Yale School of Medicine.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MESOBLAST LIMITED 0,02% | 27-08-2026 | 287.500 ( 0,02% ) | 486 246 $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MESOBLAST LIMITED | Directeur/Bestuurslid | 24-03-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Florida State University
Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mesoblast Ltd.
Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau